Skip to main content

Advertisement

SpringerLink
Log in

Management of Fungal Osteoarticular Infections

  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review summarizes our current understanding of the medical and surgical management of fungal osteoarticular infections (FOAI). These infections are uncommon, heterogenous, and often severe; management is often highly dependent on expert opinion with a dearth of high-quality evidence.

Recent Findings

FOAI can be broadly categorized into three groups: native infections with endemic fungi, hematogenous infections among patients with underlying immunodeficiency, and complications of orthopedic surgery. Management of this diverse set of infections relies on careful coordination with orthopedic surgery, and attention to the patient’s overall medical and orthopedic prognosis. Extended courses of antifungal therapy are generally used, although shorter courses may be reasonable when surgical extirpation of infection is complete, and finite antifungal therapy is usually unsuccessful when infected hardware is not resected.

Summary

Future advances in management of FOAI may emerge as more is learned about eradicating biofilm-embedded persister cells, as the roles of depot and topical antifungal agents are further elucidated, and as effective therapeutic drug monitoring is developed for these uncommon, but devastating, conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Gamaletsou MN, Rammaert B, Bueno MA, Sipsas NV, Moriyama B, Kontoyiannis DP, et al. Candida arthritis: analysis of 112 pediatric and adult cases. Open Forum Infect Dis. 2016;3:ofv207.

    Article  PubMed  Google Scholar 

  2. Gamaletsou MN, Rammaert B, Bueno MA, Moriyama B, Sipsas NV, Kontoyiannis DP, et al. Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome. J Infect. 2014;68:478–93.

    Article  PubMed  Google Scholar 

  3. Rammaert B, Gamaletsou MN, Zeller V, Elie C, Prinapori R, Taj-Aldeen SJ, et al. Dimorphic fungal osteoarticular infections. Eur J Clin Microbiol Infect Dis. 2014;33:2131–40.

    Article  CAS  PubMed  Google Scholar 

  4. Blyth CC, Gomes L, Sorrell TC, da Cruz M, Sud A, Chen SCA. Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect. 2011;17:306–11.

    Article  CAS  PubMed  Google Scholar 

  5. Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016;16:100–12.

    Article  PubMed  Google Scholar 

  6. Kauffman CA, Pappas PG, Patterson TF. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013;368:2495–500.

    Article  CAS  PubMed  Google Scholar 

  7. Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013;369:1598–609. An important national outbreak associated with a single compounding pharmacy led to dozens of highly morbid CNS and osteoarticular fungal infections.

  8. Benedict K, Park BJ. Invasive fungal infections after natural disasters. Emerging Infect Dis. 2014;20:349–55.

    Article  Google Scholar 

  9. Tribble DR, Rodriguez CJ. Combat-Related Invasive Fungal Wound Infections. Curr Fungal Infect Rep. 2014;8:277–86.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wuyts J, Van Dijck P, Holtappels M. Fungal persister cells: The basis for recalcitrant infections? PLoS Pathog. 2018;14:e1007301.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Desai JV, Mitchell AP, Andes DR. Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harb Perspect Med. 2014;4.

  12. Fanning S, Mitchell AP. Fungal biofilms. PLoS Pathog. 2012;8:e1002585.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. de Barros PP, Rossoni RD, de Souza CM, Scorzoni L, Fenley JDC, Junqueira JC. Candida biofilms: an update on developmental mechanisms and therapeutic challenges. Mycopathologia. 2020;185:415–24. Review of current knowledge of Candida biofilm formation

  14. Zarnowski R, Noll A, Chevrette MG, Sanchez H, Jones R, Anhalt H, et al. Coordination of fungal biofilm development by extracellular vesicle cargo. Nat Commun. 2021;12:6235. Fascinating laboratory work further elucidates the role of extracellular vesicles, secreted by biofilm-associated Candida, in the organization and maintenance of biofilm communities.

  15. Tai DBG, Wengenack NL, Patel R, Berbari EF, Abdel MP, Tande AJ. Fungal and mycobacterial cultures should not be routinely obtained for diagnostic work-up of patients with suspected periprosthetic joint infections. Bone Joint J. 2022;104-B:53–8. In this compelling single-center study, the added value of routinely ordering AFB and fungal cultures in orthopedic infection workups was essentially nil, and the economic cost was high.

  16. Azzam K, Parvizi J, Jungkind D, Hanssen A, Fehring T, Springer B, et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am. 2009;91(Suppl 6):142–9.

    Article  PubMed  Google Scholar 

  17. Gamaletsou MN, Kontoyiannis DP, Sipsas NV, Moriyama B, Alexander E, Roilides E, et al. Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970–2011). Clin Infect Dis. 2012;55:1338–51.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bariteau JT, Waryasz GR, McDonnell M, Fischer SA, Hayda RA, Born CT. Fungal osteomyelitis and septic arthritis. J Am Acad Orthop Surg. 2014;22:390–401.

    Article  PubMed  Google Scholar 

  19. Goff TAJ, Rambani R, Ng AB. Current concepts in the management of periprosthetic fungal joint infection using antifungal bone cement. Curr Orthop Pract. 2014;25:169–74.

    Article  Google Scholar 

  20. Chapman SW, Dismukes WE, Proia LA, Bradsher RW, Pappas PG, Threlkeld MG, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801–12.

    Article  CAS  PubMed  Google Scholar 

  21. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112–46.

    Article  PubMed  Google Scholar 

  22. Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:1255–65.

    Article  CAS  PubMed  Google Scholar 

  23. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1–50.

    Article  PubMed  Google Scholar 

  24. Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–60.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291–322.

    Article  PubMed  Google Scholar 

  26. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, et al. Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807–25.

    Article  PubMed  Google Scholar 

  27. Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026.

    Article  PubMed  Google Scholar 

  28. Marcos-Zambrano LJ, Escribano P, Bouza E, Guinea J. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms. J Antimicrob Chemother. 2016;71:2498–501.

    Article  CAS  PubMed  Google Scholar 

  29. Pereira R, Dos Santos Fontenelle RO, de Brito EHS, de Morais SM. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol. 2021;131:11–22. An overview of biofilm production by C. albicans and review of the current armamentarium of antifungals as well as the mechanism of resistance C albicans employs against these medications.

  30. Richaud C, De Lastours V, Panhard X, Petrover D, Fantin B, Lefort A. Candida vertebral osteomyelitis (CVO) 28 cases from a 10-year retrospective study in France. Medicine (Baltimore). 2017;96:e7525.

    Article  CAS  PubMed  Google Scholar 

  31. Miller AO, Gamaletsou MN, Henry MW, Al-Hafez L, Hussain K, Sipsas NV, et al. Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention. Infect Dis (Lond). 2015;47:144–9.

    Article  CAS  PubMed  Google Scholar 

  32. Koehler P, Tacke D, Cornely OA. Aspergillosis of bones and joints - a review from 2002 until today. Mycoses. 2014;57:323–35.

    PubMed  Google Scholar 

  33. Gamaletsou MN, Walsh TJ, Sipsas NV. Epidemiology of Fungal Osteomyelitis. Curr Fungal Infect Rep. 2014;8:262–70.

    Article  Google Scholar 

  34. Gabrielli E, Fothergill AW, Brescini L, Sutton DA, Marchionni E, Orsetti E, et al. Osteomyelitis caused by Aspergillus species: a review of 310 reported cases. Clin Microbiol Infect. 2014;20:559–65.

    Article  CAS  PubMed  Google Scholar 

  35. Marchionni E, Parize P, Lefevre A, Vironneau P, Bougnoux ME, Poiree S, et al. Aspergillus spp invasive external otitis: favourable outcome with a medical approach. Clin Microbiol Infect. 2016;22:434–7.

    Article  CAS  PubMed  Google Scholar 

  36. Papachristou SG, Iosifidis E, Sipsas NV, Gamaletsou MN, Walsh TJ, Roilides E. Management of osteoarticular fungal infections in the setting of immunodeficiency. Expert Rev Anti Infect Ther. 2020;18:461–74. Contemporary review of the management of FOAI in immunodeficient hosts, with focus on the different pathogens causing FOAI and current approaches to therapeutics.

  37. Taj-Aldeen SJ, Rammaert B, Gamaletsou M, Sipsas NV, Zeller V, Roilides E, et al. Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine (Baltimore). 2015;94:e2078.

    Article  CAS  PubMed  Google Scholar 

  38. Giacobbe DR, Riccardi N, Vena A, Bassetti M. Mould infections of traumatic wounds: A brief narrative review. Infect Dis Ther. 2020;9:1–15. A narrative review of the epidemiology, diagnosis, and treatment of wound mold infections following traumatic injuries. Most of the medical literature is focused on infection following war injuries and natural disasters, but mould infections can also develop following any trauma associated with soil contamination, including agriculture and automotive injuries.

  39. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26–34. A systematic review of all cases of mucormycoses reported between 2000 and 2017, evaluating the contemporary epidemiology, clinical manifestations, and approaches to diagnosis of this invasive mycoses. Diabetes mellitus was the most common underlying comorbidity and was an independent predictor of rhino-orbital-cerebral infection.

  40. Harrasser N, Banke IJ, Hauschild M, Lenze U, Prodinger PM, Toepfer A, et al. Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment. BMC Infect Dis. 2014;14:488.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Taj-Aldeen SJ, Gamaletsou MN, Rammaert B, Sipsas NV, Zeller V, Roilides E, et al. Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century. Med Mycol. 2017;55:691–704.

    PubMed  PubMed Central  Google Scholar 

  42. Koehler P, Tacke D, Cornely OA. Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi. Crit Rev Microbiol. 2016;42:158–71.

    Article  PubMed  Google Scholar 

  43. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20 Suppl 3:5–26.This review of 20 studies (77 patients in total) reviews treatment strategies including some associated with success (negative pressure wound dressings, delayed closure) and failure (muscle flaps).

  44. Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20(Suppl 3):27–46.

    Article  CAS  PubMed  Google Scholar 

  45. Lamoth F, Kontoyiannis DP. Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients. Antimicrob Agents Chemother. 2019;63. Review of the treatment of non-aspergillus invasive mold infections in immunosuppressed hosts, with a focus on drug efficacy and approaches to improving the understanding of antifungal pharmacokinetics when treating these infections. The authors caution that clinical outcome is more dependent on improvement of underlying immunodeficiency and the successful of surgical debridement than the choice of anti-fungal.

  46. Srikanta D, Santiago-Tirado FH, Doering TL. Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast. 2014;31:47–60.

    Article  CAS  PubMed  Google Scholar 

  47. Adiwardana NS, Morás J de A, Bernardo LL, Klautau GB, Queiroz W, Vidal JE. Chronic skull osteomyelitis due to Cryptococcus neoformans: first case report in an HIV-infected patient. Braz J Infect Dis. 2018;22:499–502.

  48. Zhou H-X, Lu L, Chu T, Wang T, Cao D, Li F, et al. Skeletal cryptococcosis from 1977 to 2013. Front Microbiol. 2014;5:740.

    PubMed  Google Scholar 

  49. Medaris LA, Ponce B, Hyde Z, Delgado D, Ennis D, Lapidus W, et al. Cryptococcal osteomyelitis: a report of 5 cases and a review of the recent literature. Mycoses. 2016;59:334–42.

    Article  PubMed  Google Scholar 

  50. Morris E, Wolinsky E. Localized osseous cryptococcosis. A case report. J Bone Joint Surg Am. 1965;47:1027–9.

    Article  CAS  PubMed  Google Scholar 

  51. Corral JE, Lima S, Quezada J, Samayoa B, Arathoon E. Cryptococcal osteomyelitis of the skull. Med Mycol. 2011;49:667–71.

    PubMed  Google Scholar 

  52. Cash JB, Goodman NL. Cryptococcal infection of the temporal bone. Diagn Microbiol Infect Dis. 1983;1:257–60.

    Article  CAS  PubMed  Google Scholar 

  53. Rerolle J-P, Szelag J-C, Diaconita M, Paraf F, Aldigier J-C, Le Meur Y. Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient. Am J Kidney Dis. 2005;46:e113–7.

    Article  PubMed  Google Scholar 

  54. Baddley JW, Chen SC-A, Huisingh C, Benedict K, DeBess EE, Galanis E, et al. MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii Infections. Clin Infect Dis. 2021;73:1133–41. A descriptive analysis of a large cohort of patients delineating differences in epidemiology and clinical presentation of cryptococcosis 2nd to C neoformans versus C gattii. Patients with C. gattii had a longer time to diagnosis, were less immunosuppressed and pulmonary disease was more common than in patient with C. neoformans

  55. Adam RD, Elliott SP, Taljanovic MS. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med. 2009;122:770–7.

    Article  PubMed  Google Scholar 

  56. Austen S, van der Weegen W, Verduin CM, van der Valk M, Hoekstra HJ. Coccidioidomycosis infection of a total knee arthroplasty in a nonendemic region. J Arthroplasty. 2013;28(375):e13-5.

    Google Scholar 

  57. Taljanovic MS, Adam RD. Musculoskeletal coccidioidomycosis. Semin Musculoskelet Radiol. 2011;15:511–26.

    Article  PubMed  Google Scholar 

  58. Koutserimpas C, Naoum S, Raptis K, Vrioni G, Samonis G, Alpantaki K. Skeletal infections caused by coccidioides species. Diagnostics (Basel). 2022;12. A review of all published cases of skeletal coccidioides infection with descriptions of patient characteristics, clinical presentation, and surgical and medical approaches to treatment, as well as a description of the epidemiology of this FAOI. The most common site of infection was the spine (82.6%) followed by the foot (6.5%).

  59. Johnson RH, Sharma R, Kuran R, Fong I, Heidari A. Coccidioidomycosis: a review. J Investig Med. 2021;69:316–23. A thorough review of the current approach to diagnosis and management of Cryptococcosis, and description of the wide array of clinical manifestations of this infection. It is predominantly a pulmonary disease, but when disseminated, can lead to CNS, bone, and skin involvement.

  60. Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: An emerging or a neglected disease? PLoS Negl Trop Dis. 2018;12:e0006046.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Amona FM, Denning DW, Moukassa D, Develoux M, Hennequin C. Histoplasmosis in the Republic of Congo dominated by African histoplasmosis, Histoplasma capsulatum var. duboisii. PLoS Negl Trop Dis. 2021;15:e0009318.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Compton J, Vander Voort W, Willey M, Sekar P. A case of Histoplasma capsulatum variety capsulatum septic arthritis successfully treated with surgery, systemic antifungals, and local amphotericin cement beads. Int J Infect Dis. 2018;77:23–5.

    Article  PubMed  Google Scholar 

  63. Martin-Iguacel R, Kurtzhals J, Jouvion G, Nielsen SD, Llibre JM. Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case Report Lit Rev Infect. 2014;42:611–20.

    CAS  Google Scholar 

  64. Chapman SW, Lin AC, Hendricks KA, Nolan RL, Currier MM, Morris KR, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect. 1997;12:219–28.

    CAS  PubMed  Google Scholar 

  65. Azar MM, Assi R, Relich RF, Schmitt BH, Norris S, Wheat LJ, et al. Blastomycosis in Indiana: Clinical and Epidemiologic Patterns of Disease Gleaned from a Multicenter Retrospective Study. Chest. 2015;148:1276–84.

    Article  PubMed  Google Scholar 

  66. Oppenheimer M, Embil JM, Black B, Wiebe L, Limerick B, MacDonald K, et al. Blastomycosis of bones and joints. South Med J. 2007;100:570–8.

    Article  PubMed  Google Scholar 

  67. McBride JA, Gauthier GM, Klein BS. Clinical manifestations and treatment of blastomycosis. Clin Chest Med. 2017;38:435–49.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Jain R, Singh K, Lamzabi I, Harbhajanka A, Gattuso P, Reddy VB. Blastomycosis of bone: a clinicopathologic study. Am J Clin Pathol. 2014;142:609–16.

    Article  PubMed  Google Scholar 

  69. Trad HS, Trad CS, Elias Junior J, Muglia VF. Revisão radiológica de 173 casos consecutivos de paracoccidioidomicose. Radiol Bras. 2006;39:175–9.

    Article  Google Scholar 

  70. Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993;6:89–117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Amstalden EM, Xavier R, Kattapuram SV, Bertolo MB, Swartz MN, Rosenberg AE. Paracoccidioidomycosis of bones and joints. A clinical, radiologic, and pathologic study of 9 cases. Medicine (Baltimore). 1996;75:213–25.

    Article  CAS  PubMed  Google Scholar 

  72. Paniago AMM, Aguiar JIA, Aguiar ES, da Cunha RV, de Oliveira Leite Pereira GR, Londero AT, et al. [Paracoccidioidomycosis: a clinical and epidemiological study of 422 cases observed in Mato Grosso do Sul]. Rev Soc Bras Med Trop. 2003;36:455–9.

    Article  PubMed  Google Scholar 

  73. Lima Júnior FVA, Savarese LG, Monsignore LM, Martinez R, Nogueira-Barbosa MH. Computed tomography findings of paracoccidiodomycosis in musculoskeletal system. Radiol Bras. 2015;48:1–6.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Costa MAB, Carvalho TN, de Araújo Júnior CR, Borba AOC, Veloso GA, Teixeira K-I-SS. Teixeira K-I-SS Manifestações extrapulmonares da paracoccidioidomicose. Radiol Bras. 2005;38:45–52.

    Article  Google Scholar 

  75. Monsignore LM, Martinez R, Simão MN, Teixeira SR, Elias J, Nogueira-Barbosa MH. Radiologic findings of osteoarticular infection in paracoccidioidomycosis. Skeletal Radiol. 2012;41:203–8.

    Article  PubMed  Google Scholar 

  76. Correa-de-Castro B, Pompilio MA, Odashiro DN, Odashiro M, Arão-Filho A, Paniago AMM. Unifocal bone paracoccidioidomycosis. Brazil Am J Trop Med Hyg. 2012;86:470–3.

    Article  PubMed  Google Scholar 

  77. Shikanai-Yasuda MA, Mendes RP, Colombo AL, de Queiroz-Telles F, Kono ASG, Paniago AMM, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;50:715–40.

    Article  PubMed  Google Scholar 

  78. Le T, Wolbers M, Chi NH, Quang VM, Chinh NT, Lan NPH, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City. Viet Nam Clin Infect Dis. 2011;52:945–52.

    Article  PubMed  Google Scholar 

  79. Wei H-Y, Liang W-J, Li B, Wei L-Y, Jiang A-Q, Chen W-D, et al. Clinical characteristics and risk factors of Talaromyces marneffei infection in human immunodeficiency virus-negative patients: A retrospective observational study. World J Emerg Med. 2021;12:281–6. An analysis of the clinical presentation and outcomes of a cohort of HIV-negative patients with T. marneffei at a single institution in China.

  80. Qiu Y, Liao H, Zhang J, Zhong X, Tan C, Lu D. Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study. BMC Infect Dis. 2015;15:525.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Fichman V, Freitas DFS, do Valle ACF, de Souza RV, Curi ALL, Valete-Rosalino CM, et al. Severe sporotrichosis treated with amphotericin B: A 20-year cohort study in an endemic area of zoonotic transmission. J Fungi (Basel). 2022;8. Analysis of a large cohort of patients with severe sporotrichosis treated at a specialty reference hospital in Rio de Janeiro in order to better understand the effectiveness and safety of treatment with amphotericin B. A survival analysis showed an association between cure and the absence of bone, upper airway, and CNS disease.

  82. Barros MB de L, de Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev. 2011;24:633–54.

  83. Hajjeh R, McDonnell S, Reef S, Licitra C, Hankins M, Toth B, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis. 1997;176:499–504.

    Article  CAS  PubMed  Google Scholar 

  84. Ramos V, Astacio GS-M, do Valle ACF, de Macedo PM, Lyra MR, Almeida-Paes R, et al. Bone sporotrichosis: 41 cases from a reference hospital in Rio de Janeiro, Brazil. PLoS Negl Trop Dis. 2021;15:e0009250. An analysis of 41 patients with bone sporotrichosis treated at a sporotrichosis specialty center in Brazil between 1999 and 2016, with a focus on epidemiology, natural history, and treatment approaches. The most common sites of infection were the hands (58.5%), feet (41.5%) and tibia (26.8%), with 61% of the patients presenting with multifocal bone infection.

  85. Paixão AG, Galhardo MCG, Almeida-Paes R, Nunes EP, Gonçalves MLC, Chequer GL, et al. The difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDS. AIDS Res Ther. 2015;12:16.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27:302–45.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Jakobs O, Schoof B, Klatte TO, Schmidl S, Fensky F, Guenther D, et al. Fungal periprosthetic joint infection in total knee arthroplasty: a systematic review. Orthop Rev (Pavia). 2015;7:5623.

    Article  PubMed  Google Scholar 

  88. Kuiper JWP, van den Bekerom MPJ, van der Stappen J, Nolte PA, Colen S. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop. 2013;84:517–23.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1-25.

    Article  PubMed  Google Scholar 

  90. Brown TS, Petis SM, Osmon DR, Mabry TM, Berry DJ, Hanssen AD, et al. Periprosthetic joint infection with fungal pathogens. J Arthroplasty. 2018;33:2605–12.

    Article  PubMed  Google Scholar 

  91. Hwang BH, Yoon JY, Nam CH, Jung KA, Lee SC, Han CD, et al. Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br. 2012;94:656–9.

    Article  CAS  PubMed  Google Scholar 

  92. Klatte TO, Kendoff D, Kamath AF, Jonen V, Rueger JM, Frommelt L, et al. Single-stage revision for fungal peri-prosthetic joint infection: a single-centre experience. Bone Joint J. 2014;96-B:492–6.

  93. Baecker H, Frieler S, Geßmann J, Pauly S, Schildhauer TA, Hanusrichter Y. Three-stage revision arthroplasty for the treatment of fungal periprosthetic joint infection: outcome analysis of a novel treatment algorithm: a prospective study. Bone & Joint Open. 2021;2:671–8. 16 of 18 fungal PJI were eradicated in this single-center retrospective study of a three-stage approach with prolonged systemic antifungal therapy.

  94. Simonian PT, Brause BD, Wickiewicz TL. Candida infection after total knee arthroplasty. Management without resection or amphotericin B. J Arthroplasty. 1997;12:825–9.

    Article  CAS  PubMed  Google Scholar 

  95. Fusini F, Colò G, Rava A, Sabatini L, Massè A, Aprato A, et al. Candida periprosthetic infection of the knee: a systematic review of surgical treatments and clinical outcomes. Eur J Orthop Surg Traumatol. 2022; This systematic review of 116 published cases of Candida PJI suggests the overall quality of literature is poor, but that two-stage exchange me be preferable and associated with better outcomes overall.

  96. Blecher R, Yilmaz E, Moisi M, Oskouian RJ, Chapman J. Extreme lateral interbody fusion complicated by fungal osteomyelitis: case report and quick review of the literature. Cureus. 2018;10:e2719.

    PubMed  PubMed Central  Google Scholar 

  97. Wajchenberg M, Astur N, Kanas M, Camargo TZS, Wey SB, Martins DE. Candida parapsilosis Infection after Lumbosacral Arthrodesis with a PEEK TLIF Interbody Fusion Device: Candida infections after spinal surgery are rare but serious, and a combined medical and surgical approach with extended antifungals was associated with a good outcome in this case report.

  98. De Meo D, Cera G, Ceccarelli G, Castagna V, Aronica R, Pieracci EM, et al. Candida fracture-related infection: a systematic review. J Bone Joint Infect. 2021;6:321–8.

    Article  Google Scholar 

  99. Mertens B, Van Daele R, Depypere M, Lagrou K, Debaveye Y, Wauters J, et al. Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review. Antibiotics (Basel). 2022;11. Isavuconazole was associated with eradication of infection — but not fracture healing — in this case report. It may be an effective agent in such cases.

  100. Arıkan AA, Omay O, Kanko M, Horuz E, Yağlı G, Kağan EY, et al. Treatment of Candida sternal infection following cardiac surgery - a review of literature. Infect Dis (Lond). 2019;51:1–11. This review of 77 published cases of sternal infections noted poor outcomes with muscle flap coverage, and better outcomes with delayed wound closure and vacuum dressings.

  101. Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother. 2004;48:3291–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Clin Infect Dis. 2015;61 Suppl 6:S618–21.

  103. Hoyer AR, Johnson CJ, Hoyer MR, Kernien JF, Nett JE. Echinocandin Treatment of Candida albicans Biofilms Enhances Neutrophil Extracellular Trap Formation. Antimicrob Agents Chemother. 2018;62.

  104. Cunningham B, McLaren AC, Pauken C, McLemore R. Liposomal formulation increases local delivery of amphotericin from bone cement: a pilot study. Clin Orthop Relat Res. 2012;470:2671–6.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Harmsen S, McLaren AC, Pauken C, McLemore R. Amphotericin B is cytotoxic at locally delivered concentrations. Clin Orthop Relat Res. 2011;469:3016–21.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Rouse MS, Heijink A, Steckelberg JM, Patel R. Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clin Orthop Relat Res. 2011;469:1466–9.

    Article  PubMed  Google Scholar 

  107. Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009;43:1606–15. Sciwheel

Download references

Author information

Authors and Affiliations

  1. Hospital for Special Surgery and Weill Cornell Medicine, 535 E 70th St, New York, NY, 10021, USA

    Michael W. Henry & Andy O. Miller

Authors
  1. Michael W. Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andy O. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andy O. Miller.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Henry, M.W., Miller, A.O. Management of Fungal Osteoarticular Infections. Curr Fungal Infect Rep 17, 25–35 (2023). https://doi.org/10.1007/s12281-023-00453-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-023-00453-5

Keywords

Search

Navigation